Your browser doesn't support javascript.
loading
Autism-linked NLGN3 is a key regulator of gonadotropin-releasing hormone deficiency.
Oleari, Roberto; Lettieri, Antonella; Manzini, Stefano; Paganoni, Alyssa; André, Valentina; Grazioli, Paolo; Busnelli, Marco; Duminuco, Paolo; Vitobello, Antonio; Philippe, Christophe; Bizaoui, Varoona; Storr, Helen L; Amoruso, Federica; Memi, Fani; Vezzoli, Valeria; Massa, Valentina; Scheiffele, Peter; Howard, Sasha R; Cariboni, Anna.
Afiliação
  • Oleari R; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
  • Lettieri A; CRC Aldo Ravelli for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan 20142, Italy.
  • Manzini S; Department of Health Sciences, University of Milan, Milan 20142, Italy.
  • Paganoni A; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
  • André V; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
  • Grazioli P; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
  • Busnelli M; Department of Health Sciences, University of Milan, Milan 20142, Italy.
  • Duminuco P; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
  • Vitobello A; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Cusano Milanino 20095, Italy.
  • Philippe C; Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, Fédération Hospitalo-Universitaire (FHU) TRANSLAD, CHU Dijon Bourgogne, Dijon 21079, France.
  • Bizaoui V; INSERM UMR 1231 GAD (Génétique des Anomalies du Développement), Université de Bourgogne, Dijon 21070, France.
  • Storr HL; Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, Fédération Hospitalo-Universitaire (FHU) TRANSLAD, CHU Dijon Bourgogne, Dijon 21079, France.
  • Amoruso F; INSERM UMR 1231 GAD (Génétique des Anomalies du Développement), Université de Bourgogne, Dijon 21070, France.
  • Memi F; Genetics and Neurodevelopment, Centre Hospitalier de l'Estran, Pontorson 50170, France.
  • Vezzoli V; Centre for Endocrinology William Harvey Research Institute Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
  • Massa V; Royal London Children's Hospital, Barts Health NHS Trust, London E1 1BB, UK.
  • Scheiffele P; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
  • Howard SR; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge CB2 0AW, UK.
  • Cariboni A; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Cusano Milanino 20095, Italy.
Dis Model Mech ; 16(3)2023 03 01.
Article em En | MEDLINE | ID: mdl-36810932
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Autístico Limite: Humans Idioma: En Revista: Dis Model Mech Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Autístico Limite: Humans Idioma: En Revista: Dis Model Mech Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália